Search research articles
Contact Us
Filters
Showing results (151-160 of 417) with videos related to
Page
of 42
Sort By:
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
|
March 27, 2019
Exercise and Cognitive Training as a Strategy to Improve Neurocognitive Outcomes in Heart Failure: A Pilot Study
Rebecca A Gary, Sudeshna Paul, Elizabeth Corwin, et al.
European Heart Journal
|
April 20, 2020
Chronotherapy in hypertension: the devil is in the details
Greg Guthrie, Neil Poulter, Thomas Macdonald, et al.
European Heart Journal
|
March 26, 2019
Effects of renal denervation on kidney function and long-term outcomes: 3-year follow-up from the Global SYMPLICITY Registry
Felix Mahfoud, Michael Böhm, Roland Schmieder, et al.
American Journal of Nephrology
|
September 4, 2018
Patiromer to Enable Spironolactone Use in the Treatment of Patients with Resistant Hypertension and Chronic Kidney Disease: Rationale and Design of the AMBER Study
Rajiv Agarwal, Patrick Rossignol, Dahlia Garza, et al.
Diabetes, Obesity & Metabolism
|
September 6, 2019
Intensive glucose-lowering and the risk of vascular events and premature death in patients with decreased kidney function: The ADVANCE trial
Toshiaki Ohkuma, Sophia Zoungas, Min Jun, et al.
Journal of Occupational and Environmental Medicine
|
October 30, 2013
Pesticide risk perception and biomarkers of exposure in Florida female farmworkers
Jennifer D Runkle, J Antonio Tovar-Aguilar, Eugenia Economos, et al.
Hypertension (Dallas, Tex. : 1979)
|
December 11, 2013
Effects of combination of perindopril, indapamide, and calcium channel blockers in patients with type 2 diabetes mellitus: results from the Action In Diabetes and Vascular Disease: Preterax and Diamicron Controlled Evaluation (ADVANCE) trial
John Chalmers, Hisatomi Arima, Mark Woodward, et al.
Lancet (London, England)
|
September 20, 2019
Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): a phase 2, randomised, double-blind, placebo-controlled trial
Rajiv Agarwal, Patrick Rossignol, Alain Romero, et al.
Plos One
|
September 6, 2018
Time spent at blood pressure target and the risk of death and cardiovascular diseases
Sheng-Chia Chung, Mar Pujades-Rodriguez, Bram Duyx, et al.
Hypertension (Dallas, Tex. : 1979)
|
September 9, 2024
Resistant Hypertension and Mortality: An Observational Cohort Study
Alejandro de la Sierra, Luis M Ruilope, Natalie Staplin, et al.
Page
of 42
Search research articles
Search
Showing results (151-160 of 417) with videos related to
Sort By:
Page
of 42
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
|
March 27, 2019
Exercise and Cognitive Training as a Strategy to Improve Neurocognitive Outcomes in Heart Failure: A Pilot Study
Rebecca A Gary, Sudeshna Paul, Elizabeth Corwin, et al.
European Heart Journal
|
April 20, 2020
Chronotherapy in hypertension: the devil is in the details
Greg Guthrie, Neil Poulter, Thomas Macdonald, et al.
European Heart Journal
|
March 26, 2019
Effects of renal denervation on kidney function and long-term outcomes: 3-year follow-up from the Global SYMPLICITY Registry
Felix Mahfoud, Michael Böhm, Roland Schmieder, et al.
American Journal of Nephrology
|
September 4, 2018
Patiromer to Enable Spironolactone Use in the Treatment of Patients with Resistant Hypertension and Chronic Kidney Disease: Rationale and Design of the AMBER Study
Rajiv Agarwal, Patrick Rossignol, Dahlia Garza, et al.
Diabetes, Obesity & Metabolism
|
September 6, 2019
Intensive glucose-lowering and the risk of vascular events and premature death in patients with decreased kidney function: The ADVANCE trial
Toshiaki Ohkuma, Sophia Zoungas, Min Jun, et al.
Journal of Occupational and Environmental Medicine
|
October 30, 2013
Pesticide risk perception and biomarkers of exposure in Florida female farmworkers
Jennifer D Runkle, J Antonio Tovar-Aguilar, Eugenia Economos, et al.
Hypertension (Dallas, Tex. : 1979)
|
December 11, 2013
Effects of combination of perindopril, indapamide, and calcium channel blockers in patients with type 2 diabetes mellitus: results from the Action In Diabetes and Vascular Disease: Preterax and Diamicron Controlled Evaluation (ADVANCE) trial
John Chalmers, Hisatomi Arima, Mark Woodward, et al.
Lancet (London, England)
|
September 20, 2019
Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): a phase 2, randomised, double-blind, placebo-controlled trial
Rajiv Agarwal, Patrick Rossignol, Alain Romero, et al.
Plos One
|
September 6, 2018
Time spent at blood pressure target and the risk of death and cardiovascular diseases
Sheng-Chia Chung, Mar Pujades-Rodriguez, Bram Duyx, et al.
Hypertension (Dallas, Tex. : 1979)
|
September 9, 2024
Resistant Hypertension and Mortality: An Observational Cohort Study
Alejandro de la Sierra, Luis M Ruilope, Natalie Staplin, et al.
Page
of 42